Endoscope reprocessing devices are used in the healthcare settings for the reprocessing procedures of the endoscopes. The endoscope reprocessing devices are used to decontaminate the instruments and devices such as duodenoscopes, endoscope accessories, and others. Endoscope reprocessing devices are Class II devices cleared through the premarket notification by the Food and Drug Administration (FDA). The devices are designed to inhibit microorganisms in or on reusable endoscopes by exposing their outside surfaces and interior channels to chemical solutions. Moreover, the endoscope reprocessing devices reduce staff exposure hazards associated with aldehyde-based solutions, thus granting major safety advantage for the adoption and usage of endoscope reprocessing devices.
Rising adoption of the innovative automated endoscope reprocessors in the healthcare settings to augment the growth of endoscope reprocessing market
The rise in adoption of endoscope reprocessors in hospitals for infection prevention and control and the emergence of automated endoscope reprocessors (AER) in the healthcare settings is expected to fuel the growth of the global endoscope reprocessing device market over the forecast period. The AERs can enhance the reliability and consistency of endoscope reprocessing by standardizing several important reprocessing steps, thereby reducing the possibility of human error. The use of AERs reduces exposure of personnel to harmful chemical germicides, thereby minimizing the health problems attributed to reprocessing of endoscopes. Moreover, rising government concerns pertaining to patient safety and strong healthcare infrastructure support are the factors contributing to rise in global endoscope reprocessing device market. For instance, in 2015, the Centers for Disease Control and Prevention (CDC) has asked the Healthcare Infection Control Practices Advisory Committee (HICPAC) to issue guidelines for the improvement of facility-level training to ensure competency for endoscope reprocessing devices.
However, higher cost associated with the chemicals and consumables, infection risks after endoscopic reprocessing procedures, and complications associated with automated endoscope reprocessors are some of the factors restraining the growth of the global endoscope reprocessing market.
Global Endoscope Reprocessing Device Market Taxonomy
The global endoscope reprocessing device market is segmented on the basis of product type, modality, end user, and geography.
On the basis of product type, the global endoscope reprocessing device market is segmented into:
On the basis of modality, the global endoscope reprocessing device market is segmented into:
On the basis of end user, the global endoscope reprocessing device market is segmented into:
Rising number of endoscopic procedures in North America is expected to dominate the endoscope reprocessing devices market
Regional segmentation of the endoscope reprocessing device market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the endoscope reprocessing device market with the factors attributed to larger number of endoscopic procedures. According to the American Society for Gastrointestinal Endoscopy, 2016, approximately 20 million gastro intestinal endoscopic procedures are performed annually in the U.S. with the transmission rate of infectious agents with an estimated frequency of 1 out of 1.8 million procedures. Asia Pacific is expected to witness a drastic growth in global endoscope reprocessing device market, owing to the enhanced competition with the presence of top manufacturers and ageing population susceptible to frequent medical check-ups, thus creating a positive impact on the endoscope reprocessing devices market.
Launch of innovative automated reprocessing devices by the major players to accelerate the global endoscope reprocessing device market
The key players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, PENTAX Medical, Wassenburg Medical B.V., Steelco S.p.A., Medivators Inc., Johnson & Johnson, and Minntech Corp. The key players are mainly focused on product innovations and global expansion of the products to expand the market presence. For instance, the Getinge ED-FLOW AER (automated endoscope reprocessing) launched by Getinge Group in 2014, is the world's first true pass-through AER. The product two separate chambers and short cycles, which offers excellent capacity to reprocess 6 endoscopes per hour, providing solutions in large endoscopy departments.